Coya Therapeutics shares rise 4.67% premarket after announcing participation in the BTIG Virtual Biotechnology Conference.

martes, 22 de julio de 2025, 9:06 am ET1 min de lectura
COYA--
Coya Therapeutics, Inc. rose 4.67% in premarket trading, with the company announcing its participation in the BTIG Virtual Biotechnology Conference on July 29 – 30, 2025. This event provides an opportunity for the company to showcase its developments in biologics intended to enhance regulatory T cell (Treg) function, which is likely driving investor interest and contributing to the stock's upward movement.

Coya Therapeutics shares rise 4.67% premarket after announcing participation in the BTIG Virtual Biotechnology Conference.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios